Literature DB >> 171081

Synthesis, surface deposition, and secretion of immunoglobulins by Abelson virus-transformed lymphosarcoma cell lines.

E Premkumar, M Potter, P A Singer, M D Sklar.   

Abstract

Three Abelson virus-transformed lymphoma cell lines were established in tissue culture and the immunoglobulin biosynthesis by these cell lines was studied. Two of the cell lines (ABLS-1 and ABLS-5) were found to synthesize monomeric IgM molecules which were deposited in the cell membrane, probably to serve as an antigen receptor. The third cell line (ABLS-8) was found to synthesize membrane-associated IgM as well as cellular IgG molecules. In addition, these cell lines were found to synthesize a protein of 35,000 molecular weight which is also membrane-associated and which has the capability to bind the immunoglobulin (MAID). It is speculated that this protein might play a role in adapting the receptor immunoglobulin molecule to the hydrophobic environment of the cell membrane. The kinetics of amino acid incorporation into immunoglobulins by these cell lines show that they produce immunoglobulins at a rate which is two orders of magnitude smaller than plasmacytoma cells (MOPC 104E). These results suggest that Abelson virus transforms thymus-independent lymphocytes in various stages of maturation and these lymphocytes might be of B cell origin. The T lymphoma (P1798) used as a control cell line was found occasionally to produce minute amounts of immunoglobulin.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 171081     DOI: 10.1016/0092-8674(75)90005-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  28 in total

1.  Characterization of mouse cellular deoxyribonucleic acid homologous to Abelson murine leukemia virus-specific sequences.

Authors:  B Dale; B Ozanne
Journal:  Mol Cell Biol       Date:  1981-08       Impact factor: 4.272

2.  Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells.

Authors:  O N Witte; N Rosenberg; M Paskind; A Shields; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

3.  Aberrant splicing events that are induced by proviral integration: implications for myb oncogene activation.

Authors:  D Rosson; D Dugan; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  T-cell lymphoma lines derived from rat thymomas induced by Moloney murine leukemia virus: phenotypic diversity and its implications.

Authors:  P A Lazo; A J Klein-Szanto; P N Tsichlis
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

5.  Inducible transcription of the unrearranged kappa constant region locus is a common feature of pre-B cells and does not require DNA or protein synthesis.

Authors:  K J Nelson; D E Kelley; R P Perry
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

6.  Study of proteolytic removal of Fab delta and Fe delta determinants of lymphocyte membrane IgD using a direct rosette assay.

Authors:  J E Calvert; N R Ling; R Jefferis
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

7.  Surface immunoglobulin on cultured foetal mouse thymocytes.

Authors:  D Haustein; T E Mandel
Journal:  Immunology       Date:  1979-07       Impact factor: 7.397

8.  Hemopoietic stem cells and target cells in murine-virus-induced leukemias.

Authors:  H J Seidel
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

9.  Induction of amplified synthesis and secretion of IgM by fusion of murine 'b lymphoma with myeloma cells.

Authors:  R Laskov; K J Kim; R Asofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

10.  Abelson murine leukemia virus: structural requirements for transforming gene function.

Authors:  A Srinivasan; C Y Dunn; Y Yuasa; S G Devare; E P Reddy; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.